Edward Ian has been named PPD‘s vice president of clinical development for Asia-Pacific. Mr. Ian will be based in Singapore and will provide strategic leadership and operational oversight for PPD’s Phase II-IV business in the region.

“Edward Ian brings more than 15 years of clinical operations, central laboratory management, quality management systems and project management expertise through his long tenure with multinational companies in Asia-Pacific and the U.S.,” said Paul Colvin, executive vice president of global clinical development at PPD. “His expertise across a wide range of areas within the clinical research industry will play a significant role in advancing our strong position in this growing region.”

Mr. Ian spent six years at PRA International, where he most recently served as executive director of scientific affairs responsible for Phase I-IV clinical operations in Asia-Pacific. He also held the positions of regional director of operations and senior director of clinical operations for Asia-Pacific, where he managed daily operations, set strategy and performance standards, and collaborated on business development initiatives. He began his career as a laboratory scientist and later served as director of business development and quality assurance for a regional CRO in Taiwan where he rose to executive vice president.

PPD’s Asia-Pacific operations include nearly 1,400 people and offices in 13 countries. The company offers a full range of drug discovery and development services from the region, including operating global central laboratories in China and Singapore.